Senior Director, Clinical Safety Physician

avalynpharma

United States

On-site

USD 250,000 - 380,000

Full time

14 days+

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

Avalyn Pharma in the United States is seeking a Senior Director, Clinical Safety Physician to provide medical leadership and oversight of drug safety across its inhaled antifibrotic programs AP01, AP02, and AP03.

You will review serious adverse events, AESIs, and aggregate safety data, translate safety findings into development decisions, and lead pharmacovigilance strategies with Clinical Development, Regulatory Affairs, and external partners.

Qualifications

  • MD/DO/PhD with medical safety leadership in biotech or pharma.
  • Experience reviewing SAEs, AESIs, and risk assessments.
  • Strong knowledge of pharmacovigilance and regulatory safety requirements.
  • Ability to lead cross-functional safety teams.
  • Experience with DMC/IDMC activities.

Responsibilities

  • Provide medical safety leadership across inhaled antifibrotic programs.
  • Review SAEs, AESIs, deaths, and other safety data with clinical judgment.
  • Develop safety monitoring plans and risk mitigation strategies.
  • Collaborate with Clinical Development, Regulatory Affairs, Data Management, and PV partners.
  • Interact with health authorities and governance committees.

Skills

Medical leadership
Safety governance
Pharmacovigilance
Cross-functional collaboration
Clinical safety review

Education

MD/DO/PhD in related field

Tools

PV systems
DMC/IDMC support

Job description

About Avalyn:

Avalyn aims to transform the treatment paradigm for pulmonary fibrosis and other serious, rare respiratory diseases. The company is advancing optimized inhaled formulations of established antifibrotic medicines designed to deliver drug directly to the lungs, enhance local efficacy, and reduce systemic side effects. Avalyn's AP01 program is an optimized inhaled formulation of pirfenidone currently being evaluated in MIST, a global Phase 2b clinical trial in patients with progressive pulmonary fibrosis (PPF). AP01 has demonstrated encouraging safety and clinical activity across Phase 1b and an ongoing, multi-year open-label extension trial, with long-term data supporting the potential to preserve lung function while improving tolerability relative to historical oral pirfenidone. Avalyn's AP02 program is an optimized inhaled formulation of nintedanib currently being evaluated in AURA, a global Phase 2 clinical trial in patients with idiopathic pulmonary fibrosis (IPF). Avalyn is also advancing AP03, an inhaled fixed-dose combination of pirfenidone and nintedanib, designed to deliver multiple antifibrotic mechanisms through a single lung-targeted platform. By leveraging its proprietary drug-device approach and deep expertise in rare respiratory disease development, Avalyn aims to establish a new standard of care in pulmonary fibrosis through inhaled, lung-targeted therapies. For more information, please visit avalynpharma.com and follow the company on LinkedIn .

Position Overview:

The Senior Director, Clinical Safety Physician provides medical leadership and oversight of drug safety across Avalyn's portfolio of inhaled antifibrotic investigational products. The role is accountable for the ongoing medical evaluation, surveillance, interpretation, documentation, and communication of emerging safety data, including adverse event assessment, signal detection, and characterization of potential risks, ensuring that safety findings are appropriately incorporated into clinical development and risk management decisions. This is a hands‑on leadership role suited to a clinical‑stage, scaling biotech company. The Senior Director directly reviews adverse event cases, safety listings, and aggregate safety data, identifies and assesses emerging safety signals, and provides medical recommendations to inform ongoing study conduct and development decisions. The individual also serves as the medical safety lead across Clinical Development, Clinical Operations, Regulatory Affairs, Biostatistics, Data Management, Medical Writing, Quality Assurance, and external CRO and pharmacovigilance (PV) partners. The Senior Director integrates safety considerations into clinical development strategy and execution, establishes and oversees fit‑for‑purpose pharmacovigilance processes and systems, and provides medical safety leadership in interactions with senior leadership, governance committees, external partners, and health authorities. The Senior Director reports to the SVP Clinical Development and partners closely with cross‑functional leadership to ensure appropriate medical oversight of safety across the portfolio.

Responsibilities:
Medical Safety Leadership & Oversight

Provide medical leadership and oversight of safety across Avalyn's clinical‑stage investigational products, including the inhaled pirfenidone (AP01), nintedanib (AP02), and fixed‑dose combination (AP03) programs.

Perform medical review and assessment of serious adverse events (SAEs), adverse events of special interest (AESIs), deaths, discontinuations due to adverse events, and other medically significant events, including assessment of seriousness, causality, expectedness, and clinical significance.

Review case narratives and ensure appropriate follow‑up of medically important information.

Apply clinical judgment to distinguish drug‑related safety findings from manifestations of the underlying disease (e.g., progression of pulmonary fibrosis, acute exacerbations), concomitant illness, and background events.

Identify, evaluate, and elevate potentially important safety findings, and provide medical judgment on emerging concerns and their implications for development.

Clinical Trial Safety

Provide ongoing safety oversight of Phase 1‑3 clinical trials through periodic review of aggregate adverse events, laboratory abnormalities, vital signs, ECGs, pulmonary safety parameters, and other clinically relevant safety data.

Review blinded and, when appropriate, unblinded safety information in accordance with established study procedures.

Provide medical safety input into clinical trial design and execution, including protocols, safety monitoring plans, informed consent documents, and protocol amendments, ensuring appropriate safety assessments, monitoring requirements, and risk mitigation measures are incorporated.

Provide medical safety expertise and support Data Monitoring Committee (DMC) / Independent Data Monitoring Committee (IDMC) activities as ap

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Senior Director, Clinical Safety Physician
Senior Director, Clinical Safety Physician

Avalyn Pharma • United States

On-site
USD 260,000 - 360,000
Senior Manager, Regulatory Affairs
Senior Manager, Regulatory Affairs

avalynpharma • Boston (MA)

On-site
USD 150,000 - 210,000
Chief Medical Safety Officer – Inhaled Therapies
Chief Medical Safety Officer – Inhaled Therapies

avalynpharma • United States

On-site
USD 250,000 - 380,000
Senior Director, Clinical Safety—Inhaled Therapies
Senior Director, Clinical Safety—Inhaled Therapies

Avalyn Pharma • United States

On-site
USD 260,000 - 360,000
Senior Director, Head of Supply Chain
Senior Director, Head of Supply Chain

avalynpharma • Boston (MA)

On-site
USD 250,000 - 350,000
Senior Director, Head of Supply Chain
Senior Director, Head of Supply Chain

Avalyn Pharma Inc. • Boston (MA)

On-site
USD 240,000 - 280,000
Senior Manager, Regulatory Affairs
Senior Manager, Regulatory Affairs

Avalyn Pharma Inc. • Boston (MA)

On-site
USD 157,000 - 173,000
Senior Director, Safety Physician
Senior Director, Safety Physician

amylyx • Cambridge (MA)

On-site
USD 250,000 - 350,000
Senior Manager, CMC Technical Writing
Senior Manager, CMC Technical Writing

Avalyn Pharma Inc. • Boston (MA)

On-site
USD 150,000 - 176,000
Director, Pharmacovigilance & Drug Safety
Director, Pharmacovigilance & Drug Safety

Amneal • Piscataway Township (NJ)

On-site
USD 180,000 - 280,000